Which is positive news for the world, the University of Oxford and AstraZeneca became the first Covid-19 vaccine manufacturers to publish the results of end-stage clinical trials in a scientific journal on Tuesday, clearing a key hurdle. in the global race to develop safe and effective medicines. for the new …
Read More »
Written by Prabha Raghavan, Anuradha Mascarenhas | New Delhi, Pune | Updated: December 8, 2020 7:15:08 am Hyderabad-based Bharat Biotech has included interim data from early and mid-stage human trials of its Covaxin vaccine candidate. (Archive) In its application for emergency use approval, Hyderabad-based Bharat Biotech has included interim data …
Read More »
NEW DELHI: Hyderabad-based Bharat Biotech submitted an application for an emergency use authorization for Covaxin on Monday, becoming the third company to seek such regulatory approval in India after Pfizer and Serum Institute of India (SII) . Covaxin is the first fully locally developed candidate vaccine against Covid-19 to be …
Read More »
After US pharmaceutical giant Pfizer, Serum Institute of India (SII) applied on Sunday to the Comptroller General of Medicines of India (DCGI) for an emergency use authorization for the COVID-19 Covidshield vaccine from Oxford in the country. On Twitter, SII CEO Adar Poonawalla reported that the company has applied for …
Read More »
Adar Poonawalla has confirmed that the Serum Institute of India has applied for an emergency use authorization for the Covishield coronavirus vaccine. “As promised, before the end of 2020, @SerumInstIndia has applied for emergency use authorization for the first vaccine manufactured in India, COVISHIELD. This will save countless lives, and …
Read More »
The Serum Institute of India on Sunday became the first indigenous company to submit an application to the Comptroller General of Drugs of India (DCGI) seeking an emergency use authorization for the Oxford COVID-19 vaccine in the country citing needs not covered due to the pandemic and in the interest …
Read More »
However, distributing the vaccines in India’s first mass vaccination campaign for adults could be a daunting task. It will require expanding India’s existing cold chain capacity at breakneck speed, especially in some of the most densely populated parts of the country, where such infrastructure is very limited. It will also …
Read More »
A Chennai neurologist opined that the 40-year-old man who volunteered for the Serum Institute of India’s covid vaccine trial developed acute neurological symptoms after receiving the injection. The participant had visited the doctor after being discharged from the hospital linked to the Covishield trial site. “Clusters of clinical, electrophysiological and …
Read More »
The Serum Institute of India filed a Rs 100 million defamation lawsuit on Sunday against a Chennai-based volunteer who participated in its coronavirus vaccine trial and claimed it triggered an adverse reaction, including neurological deterioration. Serum Institute has partnered with drug maker AstraZeneca and the University of Oxford to produce …
Read More »
The Serum Institute of India issued a statement Sunday about a participant in its Covid vaccine trial who became seriously ill during the trial, stating that “there is absolutely no correlation with the vaccine trial and the medical condition of the volunteer.” Describing the allegations in the legal notice sent …
Read More »